Figure 3From: Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas Effect of somatostatin analogues on pituitary tumor size in patients with acromegaly, showing the percentage of patients with >10% tumor volume reduction after adjuvant or first-line therapy [107]. © 2005 The Endocrine Society. Reproduced with permission.Back to article page